- Home
- PMNT vs NXL Comparison
PMNT vs NXL Comparison
Compare PMNT & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMNT
- NXL
- Stock Information
- Founded
- PMNT 1984
- NXL 2010
- Country
- PMNT United Kingdom
- NXL United States
- Employees
- PMNT N/A
- NXL N/A
- Industry
- PMNT
- NXL Medical Specialities
- Sector
- PMNT
- NXL Health Care
- Exchange
- PMNT NYSE
- NXL Nasdaq
- Market Cap
- PMNT 11.2M
- NXL 10.0M
- IPO Year
- PMNT 2024
- NXL 2022
- Fundamental
- Price
- PMNT $1.01
- NXL $2.87
- Analyst Decision
- PMNT Strong Buy
- NXL Hold
- Analyst Count
- PMNT 1
- NXL 1
- Target Price
- PMNT $6.00
- NXL N/A
- AVG Volume (30 Days)
- PMNT 443.6K
- NXL 377.2K
- Earning Date
- PMNT 02-14-2025
- NXL 03-26-2025
- Dividend Yield
- PMNT N/A
- NXL N/A
- EPS Growth
- PMNT N/A
- NXL N/A
- EPS
- PMNT N/A
- NXL N/A
- Revenue
- PMNT $21,307,000.00
- NXL $162,078.00
- Revenue This Year
- PMNT $3.91
- NXL $56.86
- Revenue Next Year
- PMNT $29.32
- NXL $167.44
- P/E Ratio
- PMNT N/A
- NXL N/A
- Revenue Growth
- PMNT N/A
- NXL 26.00
- 52 Week Low
- PMNT $0.66
- NXL $0.30
- 52 Week High
- PMNT $5.35
- NXL $4.49
- Technical
- Relative Strength Index (RSI)
- PMNT N/A
- NXL 42.81
- Support Level
- PMNT N/A
- NXL $2.80
- Resistance Level
- PMNT N/A
- NXL $3.54
- Average True Range (ATR)
- PMNT 0.00
- NXL 0.38
- MACD
- PMNT 0.00
- NXL -0.02
- Stochastic Oscillator
- PMNT 0.00
- NXL 14.53
About PMNT PERFECT MOMENT LTD
Perfect Moment Ltd is a company which is a luxury lifestyle brand that combines fashion and technical performance for its ranges of skiwear, outerwear, swimwear, and activewear. It operates at the intersection of luxury fashion and multi-channel commerce. Although the Company is organized fundamentally as one business segment which is product sales, the Company's revenues are primarily split between three geographic areas which are the U. S., Europe, and the UK.
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.